date:Aug 13, 2014
cheduled for November 2014. This will include updated financial targets.
Outlook 2014
For the remainder of the year we expect similar market circumstances as in H1 2014. For the Biobased Food Ingredients segment we see some early signs of volume growth improvement, whereas in the Biochemicals segment the comparables versus last year for volume growth will become more challenging as the year progresses. The capex level in H2 is expected to be lower compared to H1 as major capex outlays have bee